Tumor cell heterogeneity: Impact on mechanisms of therapeutic drug resistance

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 4, 1997, Pages 789-795

  Richardson, Mary E ^a,b   Siemann, Dietmar W ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b Proctor and Gamble Pharmaceuticals   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cyclophosphamide; Drug resistance; Heterogeneity; KHT sarcoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; CELL SURFACE RECEPTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE TRANSFERASE; MELPHALAN;

ANIMAL CELL; ARTICLE; CANCER SURVIVAL; CELL HETEROGENEITY; CELL POPULATION; CELL PROTECTION; CELL SURVIVAL; CROSS RESISTANCE; ENZYME ACTIVITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TUMOR CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MELPHALAN; MICE; NEOPLASM PROTEINS; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0030694206     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00469-0     Document Type: Article

References (22)

1. Aukerman, S. L.; Fidler, I. J. The heterogeneous nature of metastatic neoplasms: Relevance to biotherapy. In: Oldman, R. K., ed. Principles of cancer therapy. New York: Raven Press; 1987:21-47.
2. Barranco, S. C.; Drewinko, B.; Humphrey, R. M. Differential response by human melanoma cells to l,3-bis-(2-chloroethyl)1-nitrosourea and bleomycin. Mutat. Res. 19:277-280; 1973.
3. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254; 1976.
4. Byers, V. S.; Johnston, J. O. Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors. Cancer Res. 37:3173-3183; 1977.
5. Chan, K. K.; Hong, P. S.; Tutsch, K.; Trump, D. L. Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508. Cancer Res. 54:6421-6429; 1994.
6. Colvin, M.; Hilton, J. Cellular resistance to cyclophosphamide. In: Mechanisms of drug resistance in neoplastic cells. New York: Academic Press; 1988:161-171.
7. Dexter, D. L.; Calabresi, P. Intraneoplastic diversity. Biochem. Biophys. Acta 695:97-112; 1982.
8. Fidler, I. J.; Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893-895; 1977.
9. Frondoza, C. G.; Triveli, S. M.; Humphrey, R. L. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line. Cancer Treat. Rep. 66:1535-1544; 1982.
10. Habig, W. H.; Jakoby, W. B. Assays for differentiation of glutathione S-transferases. In: Jakoby, W. B., ed. Methods in enzymology. New York: Academic Press; 1981:398-405.
11. Hilton, J. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res. 44:5156-5160; 1984.
12. Koelling, T. M.; Yeager, A. M.; Hilton, J.; Haynie, D. T.; Wiley, J. M. Development and characterization of a cyclophosphamide-resistant subline of acute myeloid leukemia in the Lewis X Brown Norway hybrid rat. Blood 76:1209-1213; 1990.
13. Lee, F. Y. Glutathione diminishes the anti-tumor activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites. Br. J. Cancer 63:45-50; 1990.
14. Lee, F. Y.; Vessey, A. R.; Siemann, D. W. Glutathione as a determinant of cellular response to doxorubicin. NCI Monogr. 6:211-215; 1988.
15. McGown, A. T.; Fox, B. W. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother. Pharmacol. 17:223-226; 1986.
16. Mitelman, F.; Mark, J.; Levan, G.; Levan, A. Tumor etiology and chromosomal pattern. Science 176:1340-1341; 1972.
17. Pallante, S. L.; Lisek, C. A.; Dulik, D. M.; Fenselau, C. Glutathione conjugates. Immobilized enzyme synthesis and characterization by fast atom bombardment mass spectrometry. Drug Metab. Dispos. 14:313-318; 1986.
18. Richardson, M. E.; Siemann, D. W. Thiol manipulation as a means of overcoming drug resistance in a novel cyclophosphamide-induced resistant cell line. Int. J. Radiat. Oncol. Biol. Phys. 22:781-784; 1992.
19. Russo, J.; Hilton, J. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res. 48:2963-2968; 1988.
20. Siemann, D. W.; Lord, E. M.; Keng, P. C.; Wheeler, K. T. Cell subpopulations dispersed from solid tumors and separated by centrifugal elutriation. Br. J. Cancer 44:100-108; 1987.
21. Sreerama, L.; Sladek, N. E. Apparently resistant-irrelevant elevated aldehyde dehydrogenase-3 activity in a breast adenocarcinoma cell line exhibiting oxazaphosporine-specific acquired resistance. Proc. Am. Assoc. Cancer Res. 32:352; 1991.
22. Yusa, K.; Hamada, H.; Tsuruo, T. Comparison of glutathione S-transferase activity between drug-resistant and sensitive human tumor cells: Is glutathione S-transferase associated with multidrug resistance? Cancer Chemother. Pharmacol. 22:17-20; 1988.